Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics

NCT ID: NCT00739752

Last Updated: 2018-11-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1747 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-06-30

Study Completion Date

2007-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to evaluate two sets of interventions to increase acceptance of hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD) clinics. The 1st set of interventions, with 3 levels, is based on message framing. The 3 levels are: 1. information only; 2. gain-framed message; and 3. loss-framed message. The 2nd set of interventions, with 2 levels, involves how the vaccine is recommended by the health care provider. The 2 levels are: 1. HBV vaccine offered; and 2. HBV vaccine recommended. The outcome of interest is1st dose acceptance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to evaluate two sets of interventions to increase acceptance of hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD) clinics. The 1st specific aim is to assess the effect of message-framing on vaccine acceptance. Framing theory suggests that positively framed messages (i.e., benefits of getting vaccine) are more effective than negatively framed messages (i.e., dangers of not getting vaccine) in stimulating preventive health behaviors. Research on Framing Theory and engagement in health behaviors suggests also that the effects may be moderated by other attitudinal factors, including perceived risk of the behavior and degree of involvement in the message. The 2nd aim is to evaluate the effect of provider-based interventions. Prior research suggests that recommendations by health providers are very important in patients' decisions regarding acceptance of health care procedures. Patients (18 years and older) will be recruited and followed from Chicago and Indianapolis STD clinics during routine medical visits. An audio computer-assisted self-interview (A-CASI) will cover demographics, risk behaviors, and perceived risk associated with vaccination. Subjects then will be randomized to receive a gain-framed, loss-framed, or information only message regarding HBV immunization (also delivered by A-CASI). Upon completion of the message-framing intervention, subjects will complete additional attitude questions via A-CASI. Upon completion of the A-CASI subjects will be randomly assigned to one of two provider intervention conditions: 1. vaccine offered or 2. vaccine recommended. For both conditions free HBV immunization will be provided by a nurse practitioner. Subsequently, postcard reminders will be sent and phone call reminders made for follow-up appointments for those receiving the first and second doses of vaccine. The primary outcome measure is HBV vaccination.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis B Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

2 X 3 Factorial Design
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-Framed-Offered

Non-Framed, Information Only Condition. Vaccine Offered.

Group Type EXPERIMENTAL

Non-Framed-Offered

Intervention Type BEHAVIORAL

Subjects received information only and are offered the vaccine.

Non-Framed-Recommended

Non-Framed, Information Only Condition. Vaccine Recommended.

Group Type EXPERIMENTAL

Non-Framed-Recommended

Intervention Type BEHAVIORAL

Subjects receive information only and are recommended the vaccine.

Gain-Framed-Offered

Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Offered.

Group Type EXPERIMENTAL

Gain-Framed-Offered

Intervention Type BEHAVIORAL

Subjects receive gain-framed messages and are offered the vaccine.

Gain-Framed-Recommended

Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Recommended.

Group Type EXPERIMENTAL

Gain-Framed-Recommended

Intervention Type BEHAVIORAL

Subjects receive gain-framed messages and are recommended the vaccine.

Loss-Framed-Offered

Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Offered.

Group Type EXPERIMENTAL

Loss-Framed-Offered

Intervention Type BEHAVIORAL

Subjects receive loss-framed messages and are offered the vaccine.

Loss-Framed-Recommended

Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Recommended.

Group Type EXPERIMENTAL

Loss-Framed-Recommended

Intervention Type BEHAVIORAL

Subjects receive loss-framed messages and are recommended the vaccine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Framed-Offered

Subjects received information only and are offered the vaccine.

Intervention Type BEHAVIORAL

Non-Framed-Recommended

Subjects receive information only and are recommended the vaccine.

Intervention Type BEHAVIORAL

Gain-Framed-Offered

Subjects receive gain-framed messages and are offered the vaccine.

Intervention Type BEHAVIORAL

Gain-Framed-Recommended

Subjects receive gain-framed messages and are recommended the vaccine.

Intervention Type BEHAVIORAL

Loss-Framed-Offered

Subjects receive loss-framed messages and are offered the vaccine.

Intervention Type BEHAVIORAL

Loss-Framed-Recommended

Subjects receive loss-framed messages and are recommended the vaccine.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 and older males and females
* No prior self-reported history of HBV immunization or infection
* Fluent in English
* Not known to be HIV positive.

Exclusion Criteria

* Under age 18
* Received any prior HBV vaccination
* Prior infection of Hepatitis B
* Unable to read or comprehend the English language
* HIV positive
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role collaborator

Indiana University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gregory Zimet

Professor of Pediatrics & Clinical Psychology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gregory D Zimet, PhD

Role: PRINCIPAL_INVESTIGATOR

Indiana University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chicago Department of Public Health

Chicago, Illinois, United States

Site Status

Bell Flower Clinic

Indianapolis, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Cox AD, Cox D, Zimet G. Promoting prevention and early detection: The impact of message framing, product function and perceived product risk. J Marketing 2006;70:79-91.

Reference Type RESULT

Kasting ML, Head KJ, Cox D, Cox AD, Zimet GD. The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial. Prev Med. 2019 Oct;127:105798. doi: 10.1016/j.ypmed.2019.105798. Epub 2019 Aug 9.

Reference Type DERIVED
PMID: 31404569 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AI049644

Identifier Type: NIH

Identifier Source: secondary_id

View Link

0205-04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Partner Notification Intervention for STD Clinics.
NCT00207571 COMPLETED PHASE1/PHASE2